212 related articles for article (PubMed ID: 21909684)
1. Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.
Liao M; Tong P; Zhao J; Zhang Y; Li Z; Wang J; Feng X; Hu M; Pan Y
Pathol Oncol Res; 2012 Apr; 18(2):397-403. PubMed ID: 21909684
[TBL] [Abstract][Full Text] [Related]
2. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.
Kim JM; Kwon CH; Joh JW; Ko JS; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
World J Surg Oncol; 2013 Apr; 11():92. PubMed ID: 23618082
[TBL] [Abstract][Full Text] [Related]
8. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
9. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma.
Shin E; Yu YD; Kim DS; Won NH
Pathol Oncol Res; 2014 Jul; 20(3):667-75. PubMed ID: 24619866
[TBL] [Abstract][Full Text] [Related]
11. S100A14 promotes the growth and metastasis of hepatocellular carcinoma.
Zhao FT; Jia ZS; Yang Q; Song L; Jiang XJ
Asian Pac J Cancer Prev; 2013; 14(6):3831-6. PubMed ID: 23886191
[TBL] [Abstract][Full Text] [Related]
12. MMP-1/PAR-1 signal transduction axis and its prognostic impact in esophageal squamous cell carcinoma.
Peng HH; Zhang X; Cao PG
Braz J Med Biol Res; 2012 Jan; 45(1):86-92. PubMed ID: 22086466
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of matrix metalloprotease-1/protease-activated receptor-1 axis in patients with prostate cancer.
Wang J; Liu D; Zhou W; Wang M; Xia W; Tang Q
Med Oncol; 2014 Jun; 31(6):968. PubMed ID: 24805876
[TBL] [Abstract][Full Text] [Related]
14. Associations between high levels of Notch1 expression and high invasion and poor overall survival in hepatocellular carcinoma.
Zhou L; Zhang N; Li QJ; Sun W; Zhang Y; Wang DS; Dou KF
Tumour Biol; 2013 Feb; 34(1):543-53. PubMed ID: 23179396
[TBL] [Abstract][Full Text] [Related]
15. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G
J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926
[TBL] [Abstract][Full Text] [Related]
16. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
[TBL] [Abstract][Full Text] [Related]
19. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.
Fujimoto D; Hirono Y; Goi T; Katayama K; Yamaguchi A
Anticancer Res; 2008; 28(2A):847-54. PubMed ID: 18507028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]